Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06445023
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-05-31
Brief Title:
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Sponsor:
Celldex Therapeutics
Organization:
Celldex Therapeutics
Organization Data
Organization:
Celldex Therapeutics
Class:
INDUSTRY
Study ID:
CDX0159-12
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celldex Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None